A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

计划入组 220 人 · 首次发布于 2025 年 11 月 21 日

Telemedicine Crohn's Disease and Ulcerative Colitis (TECCU)

计划入组 60 人 · 首次发布于 2016 年 10 月 24 日

Argentine Registry of Crohn's Disease and Ulcerative Colitis

计划入组 4,250 人 · 首次发布于 2025 年 9 月 4 日

Colitis Suppository

Myeloid activating target (inflammatory bowel disease/ulcerative colitis /crohn's disease)

Crohn's disease(Tscan)

ALCOHOL RESEARCH UK

United Kingdom

ASTRAZENECA UK LIMITED

United Kingdom

EUROAPI UK LIMITED

United Kingdom

NICE Recommends Eli Lilly's Mirikizumab for Crohn's Disease Treatment Following Positive Phase 3 Trial Results

University of Edinburgh Researchers Identify Key Cellular Mechanism Driving Fibrosis in Crohn's Disease

Infliximab Maintains Efficacy in Crohn's Disease and Ulcerative Colitis Regardless of Immunosuppressant Use